Categoria: Health care

Global Breast Shells Market Share, Size, Growth | Forecast 2023-28

IMARC Group, a leading market research company, has recently releases report titled “Breast Shells Market Report by Material (Polypropylene, Silicone), Sales Channel (Hospital Pharmacy (Inpatient), Retail Store, E-commerce, Wholesaler/Distributor, Direct Purchase), and Region 2023-2028” The study provides a detailed analysis of the industry, including the global breast shells market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the breast shells market?

The global breast shells market size reached US$ 73.23 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 90.69 Million by 2028, exhibiting a growth rate (CAGR) of 3.80% during 2023-2028.

What is breast shells?

Breast shells are specialized breastfeeding accessories designed to address various nursing challenges and promote overall lactation comfort for breastfeeding mothers. They are typically worn inside the bra and serve multiple purposes, including protecting sore or sensitive nipples from friction and allowing proper aeration to aid in the healing process. They can also be used to collect breast milk leaks, preventing wastage and enabling mothers to build a milk supply for future use. Some variants come with adjustable features to ensure a comfortable fit and accommodate different breast shapes and sizes. They assist in the correction of inverted or flat nipples by gently applying pressure gradually encouraging the nipples to protrude. They also provide a protective and supportive environment for breastfeeding and contribute to a more positive and comfortable nursing experience for mothers. In recent years, breast shells have gained immense traction as they aid in enhancing breastfeeding comfort and addressing common nursing difficulties, thus supporting maternal well-being across the globe.

Request for a sample copy of this report: https://www.imarcgroup.com/breast-shells-market/requestsample

What are the growth prospects and trends in the breast shells industry?

The global breast shell market is primarily driven by the growing awareness regarding the importance of breastfeeding and the increasing emphasis on maternal well-being. Additionally, the rising prevalence of breastfeeding challenges, such as sore or sensitive nipples, has augmented the demand for breast shells, as they provide protection and relief, enhancing the overall breastfeeding experience for mothers. Moreover, the evolving lifestyle patterns and the escalating number of working mothers has amplified the need for convenient and practical breastfeeding solutions, thereby fostering market growth. Apart from this, the introduction of innovative and ergonomic designs that ensure comfort and ease of use is fueling market growth, as these features cater to the evolving preferences and requirements of breastfeeding mothers. Furthermore, supportive initiatives and campaigns by various governmental and non-governmental organizations promoting breastfeeding and maternal healthcare have accelerated the adoption of breast shells, thus contributing to market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Material:

  • Polypropylene
  • Silicone

Breakup by Sales Channel:

  • Hospital Pharmacy (Inpatient)
  • Retail Store
  • E-commerce
  • Wholesaler/Distributor
  • Direct Purchase

Breakup by Region:

  • North America (U.S. Canada)
  • Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
  • Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
  • Latin America (Brazil, Mexico)
  • Middle East Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Ameda Inc. (International Biomedical Ltd.)
  • Ardo Medical Ltd.
  • Handi-Craft Company (Dr. Brown’s Baby)
  • Koninklijke Philips N.V.
  • Medela AG

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

United States Transfection Technologies Market Size Report 2023-28

IMARC Group, a leading market research company, has recently releases report titled “United States Transfection Technologies Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the United States transfection technologies market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the United States transfection technologies market?

The United States transfection technologies market size reached US$ 359 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 557 Million by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028.

What are transfection technologies?

Transfection technologies are laboratory techniques used to introduce foreign genetic material, such as DNA or RNA, into cells. They enable researchers to study gene expression, protein function, and cellular processes. There are several transfection methods, including chemical-based, physical, and viral-mediated approaches. Chemical-based methods often use cationic lipids or polymers to form complexes with genetic material, facilitating its uptake by cells. Physical methods involve physical forces like electroporation or microinjection to deliver genetic material into cells. Viral-mediated methods use modified viruses as vectors to transfer genetic material into cells. Transfection technologies play a crucial role in molecular biology research and gene therapy applications by allowing the manipulation and modification of cellular genetic content.

Request for a sample copy of this report: https://www.imarcgroup.com/united-states-transfection-technologies-market/requestsample

What are the growth prospects and trends in the United States transfection technologies industry?

The transfection technologies industry in the United States has promising growth prospects and is expected to witness significant trends in the coming years. The increasing demand for gene therapy and genetic engineering research is driving the growth of the industry. The advancements in transfection techniques and the development of novel delivery systems are likely to enhance efficiency and specificity, expanding the market further. Additionally, the rising prevalence of genetic disorders and the need for personalized medicine are fueling the demand for transfection technologies.Furthermore, the industry is witnessing a shift towards non-viral delivery systems due to safety concerns associated with viral vectors. Non-viral methods such as electroporation, nanoparticles, and chemical-based transfection are gaining traction.

Moreover, the integration of transfection technologies with other disciplines like stem cell research and regenerative medicine is creating new opportunities.Overall, the United States transfection technologies industry is expected to experience steady growth, driven by technological advancements, increasing applications in healthcare, and the expanding scope of genetic research.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product Type:

  • Reagent
  • Instrument
  • Others

Breakup by Application:

  • Therapeutic Delivery
  • Bio-Medical Research
  • Protein Production
  • Others

Breakup by Transfection Method:

  • Lipofection
  • Eletroporation
  • Nucleofection
  • Cotransfection
  • Cationic Lipid Transfection
  • In-Vivo Transfection
  • Others

Breakup by Technology:

  • Physical Transfection
  • Biochemical Based Transfection
  • Viral-Vector Based Transfection

Breakup by End User:

  • Research Centers and Academic Institutes
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region:

  • Northeast
  • Midwest
  • South
  • West

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

Blood Bags Market – Industry Trends and Forecast 2028

IMARC Group, a leading market research company, has recently releases report titled “Blood Bags Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global blood bags market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the blood bags market?

Report Attributes Details
Market Size in 2022 US$ 265.7 Million
Market Forecast in 2028 US$ 443.2 Million
Growth rate (2023 to 2028) CAGR of 9%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is blood bags?

Blood bags are widely used for collecting, transferring, storing, and transfusing blood and various components, including plasma, cryoprecipitate, and platelets. They are widely made up of bio-compatible PVC materials and are commonly available in the form of Citrate Phosphate Dextrose Adenine (CPDA) blood bags, Saline Adenine Glucose Mannitol (SAGM) blood bags, and transfer bags. Additionally, depending on the transfusion type, blood bags can be classified into single, double, triple, and quadruple blood collection bags.

Request for a free sample copy of this report: https://www.imarcgroup.com/blood-bags-market/requestsample

What are the growth prospects and trends in the blood-bags industry?

The growing number of fatal accidents, along with rising blood transfusion procedures in the trauma centers, is primarily augmenting the demand for blood bags. Moreover, the increasing prevalence of blood-related disorders, such as hemophilia, anemia, myeloma, leukemia, etc., is also propelling the need for blood transfusion. The escalating demand for blood bags in various invasive surgical procedures in the field of neurology, oncology, cardiology, orthopedics, etc., is further bolstering the demand for blood bags. Besides this, the growing awareness towards blood donation coupled with increasing demand for plasma therapy is also fueling the market growth. In the coming years, the introduction of several blood donation programs by numerous government bodies and non-profit organizations will continue to bolster the market for blood bags on a global level.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product Type:

  • Single Blood Bag
  • Double Blood Bag
  • Triple Blood Bag
  • Quadruple Blood Bag
  • Penta Blood Bag

Breakup by Application:

  • Collection Blood Bag
  • Transfer Blood Bag

Breakup by End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Blood Banks
  • Others

Breakup by Material:

  • Poly Vinyl Chloride Blood Bag
  • Polyethylene Terephthalate Blood Bag
  • Others

Breakup by Capacity:

  • 100ml Blood Bag
  • 150ml Blood Bag
  • 250ml Blood Bag
  • 300ml Blood Bag
  • 350ml Blood Bag
  • 400ml Blood Bag
  • 450ml Blood Bag
  • 500ml Blood Bag

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • AdvaCare Pharma
  • BL Life Sciences Pvt. Ltd
  • Demophorius Healthcare Ltd.
  • Fresenius SE & Co. KGaA
  • Grifols S.A.
  • Haemonetics Corporation
  • HLL Lifecare Limited
  • Innvol Medical India Limited
  • JMS Co. Ltd.
  • Kawasumi Laboratories Inc.
  • Maco Pharma International GmbH
  • Mitra Industries Pvt. Ltd.
  • Neomedic Limited
  • Poly Medicure Ltd.
  • Span Healthcare Private Limited
  • Suru International Private Ltd.
  • Teleflex Incorporated
  • Terumo Corporation
  • The Metric Company
  • Troge Medical GmbH

Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2441&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Drug Abuse Testing Market Size and Industry Forecast 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Drug Abuse Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global drug abuse testing market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the drug abuse testing market?

Report Attributes Details
Market Size in 2022 US$ 6.6 Billion
Market Forecast in 2028 US$ 9.8 Billion
Growth rate (2023 to 2028) CAGR of 6.9%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is drug abuse testing?

Drug abuse refers to the deliberate consumption of illegal substances or the overconsumption of prescribed psychoactive and over-the-counter (OTC) medications. It can affect the mind and body and cause several disorders, including addiction. As a result, drug abuse is diagnosed by using numerous testing methods to treat related problems effectively. Drug abuse testing also aids in managing the mental status of a patient, handling seizure cases in the emergency room, identifying children and newborns at risk of exposure to illicit drugs, etc. It also finds extensive applications in workplaces where job applicants can be tested for drug usage before being hired.

Request for a free sample copy of this report: https://www.imarcgroup.com/drug-abuse-testing-market/requestsample

What are the growth prospects and trends in the drug abuse testing industry?

The growing drug dependency and substance abuse among individuals for their mind-altering characteristics, medical, non-therapeutic and medicinal uses, and other purposes, such as weight loss, enhancing athletic performance, etc., are primarily driving the drug abuse testing market across the globe. In addition to this, the rising awareness about the harmful consequences of drug abuse, which can create prominent safety and health hazards and reduce the productivity and morale of an individual, is further propelling the product demand. Besides this, the escalating need for screening of employees and job applicants for providing a safe workplace and complying with stringent laws and regulations passed by government bodies is acting as another growth-inducing factor. Additionally, the improving technologies utilized by pain management and opioid dependency clinics are fueling the demand for urine drug testing, which is catalyzing the market growth. Moreover, the emergence of automated testing and analysis for drugs of abuse with at-home testing kits is projected to drive the global drug abuse testing market over the forecasted period.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

  • Analyzers
    • Immunoassays Analyzers
    • Chromatographic Devices
    • Breath Analyzers
  • Rapid Testing Devices
    • Urine Testing Devices
    • Oral Fluid Testing Devices
  • Consumables
  • Laboratory Services

Breakup by Sample:

  • Urine
  • Oral Fluid (Saliva)
  • Hair
  • Breath
  • Others

Breakup by End User:

  • Hospitals
  • Diagnostic Laboratories
  • Forensic Laboratories
  • Workplaces
  • Others

Breakup by Region:

  • North America (U.S. & Canada)
  • Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
  • Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
  • Latin America (Brazil, Mexico)
  • Middle East & Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Drägerwerk AG & Co. KGaA
  • Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings
  • Omega Laboratories Inc.
  • Quest Diagnostics Incorporated
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • United States Drug Testing Laboratories Inc.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4388&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

United States Transfection Technologies Market Size & Share Analysis 2026

IMARC Group, a leading market research company, has recently releases report titled “United States Transfection Technologies Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” The study provides a detailed analysis of the industry, including the global United States transfection technologies market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the United States transfection technologies market?

The United States transfection technologies market is expected to exhibit moderate growth during 2021-2026.

What are transfection technologies?

Transfection technologies are laboratory techniques used to introduce foreign genetic material, such as DNA or RNA, into cells. They enable researchers to study gene expression, protein function, and cellular processes. There are several transfection methods, including chemical-based, physical, and viral-mediated approaches. Chemical-based methods often use cationic lipids or polymers to form complexes with genetic material, facilitating its uptake by cells. Physical methods involve physical forces like electroporation or microinjection to deliver genetic material into cells. Viral-mediated methods use modified viruses as vectors to transfer genetic material into cells. Transfection technologies play a crucial role in molecular biology research and gene therapy applications by allowing the manipulation and modification of cellular genetic content.

Request for a free sample copy of this report: https://www.imarcgroup.com/united-states-transfection-technologies-market/requestsample

What are the growth prospects and trends in the United States transfection technologies industry?

The transfection technologies industry in the United States has promising growth prospects and is expected to witness significant trends in the coming years. The increasing demand for gene therapy and genetic engineering research is driving the growth of the industry. The advancements in transfection techniques and the development of novel delivery systems are likely to enhance efficiency and specificity, expanding the market further. Additionally, the rising prevalence of genetic disorders and the need for personalized medicine are fueling the demand for transfection technologies.Furthermore, the industry is witnessing a shift towards non-viral delivery systems due to safety concerns associated with viral vectors. Non-viral methods such as electroporation, nanoparticles, and chemical-based transfection are gaining traction. Moreover, the integration of transfection technologies with other disciplines like stem cell research and regenerative medicine is creating new opportunities.Overall, the United States transfection technologies industry is expected to experience steady growth, driven by technological advancements, increasing applications in healthcare, and the expanding scope of genetic research.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product Type:

  • Reagent
  • Instrument
  • Others

Breakup by Application:

  • Therapeutic Delivery
  • Bio-Medical Research
  • Protein Production
  • Others

Breakup by Transfection Method:

  • Lipofection
  • Eletroporation
  • Nucleofection
  • Cotransfection
  • Cationic Lipid Transfection
  • In-Vivo Transfection
  • Others

Breakup by Technology:

  • Physical Transfection
  • Biochemical Based Transfection
  • Viral-Vector Based Transfection

Breakup by End User:

  • Research Centers and Academic Institutes
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region:

  • Northeast
  • Midwest
  • South
  • West

Ask Analyst for Customization and Browse full report with TOC List of Figure: https://www.imarcgroup.com/request?type=report&id=4243&flag=C

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Aerosol Delivery Devices Market Growth, Trends and Forecast 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Aerosol Delivery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global aerosol delivery devices market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the aerosol delivery devices market?

The global aerosol delivery devices market size reached US$ 44.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 63.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028.

What are aerosol delivery devices?

Aerosol delivery devices refer to an advanced method of drug administration wherein a drug is directly delivered to the lungs for a systemic effect. Some commonly used aerosol delivery devices include pressurized metered-dose inhalers, nebulizers, and valved holder chambers. They are generally used as rescue therapy or permanent treatment for various respiratory disorders, such as asthma, obstructive lung diseases, cystic fibrosis (CF), pulmonary arterial hypertension, and infectious pulmonary. They are also utilized in treating non-respiratory conditions, including diabetes, analgesia, thyroid disorders, and genetic diseases. They aid in lowering the dosage requirements, minimizing systemic adverse effects, and improving the ability of patients to self-administer medications. As a result, aerosol delivery devices find extensive applications in drug delivery and treatment of various medical conditions.

Request for a free sample copy of this report: https://www.imarcgroup.com/aerosol-delivery-devices-market/requestsample

What are the growth prospects and trends in the aerosol delivery devices industry?

The rising incidences of chronic respiratory diseases due to surging air pollution levels, allergens, occupational risks, and unhealthy habits like smoking represent the primary factor driving the market growth. Moreover, the sudden coronavirus disease (COVID-19) outbreak that causes acute respiratory infections among patients is another major growth-inducing factor. In addition, there has been widespread adoption of aerosol delivery devices in treating obstructive airway diseases at home and in healthcare settings. Along with this, the expanding geriatric population that is more susceptible to developing critical health conditions has augmented the product demand. Besides this, the increasing preferences for personalized drug therapy coupled with the advent of novel macromolecular medications have propelled market growth.

Furthermore, the leading manufacturers are introducing innovative product variants that assist in treating chronic inflammation and infection in the lungs and improve airway clearance in patients with CF. In line with this, the development of convenient, economical, and portable inhalation devices has accelerated product adoption rates. Apart from this, the rising usage of e-commerce channels for purchasing medical supplies and the availability of mini ultrasonic nebulizers and inhalers that have automatic memory and are easy to use while traveling are providing a positive thrust to the market growth. On account of these factors, IMARC Group expects the market value to reach US$ 63.3 Billion by 2028, expanding at a CAGR of 5.4% during 2023-2028.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

  • Dry Powder Inhalers
    • Single Dose Inhalers
    • Multi Dose Inhalers
  • Metered Dose Inhalers
    • Conventional Pressurized Inhalers
    • Soft Mist Inhalers
  • Nebulizers
    • Jet Nebulizers
    • Ultrasonic Wave Nebulizers
    • Vibrating Mesh Nebulizers

Breakup by Application:

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis
  • Non-Respiratory Diseases
    • Diabetes
    • Analgesia
    • Parkinson’s Disease

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Stores

Breakup by Region:

North America (U.S. Canada)

Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)

Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)

Latin America (Brazil, Mexico)

Middle East Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • 3M Company
  • Aerogen
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Merck & Co. Inc.
  • Metall Zug AG
  • Recipharm AB (publ)
  • Teva Pharmaceutical Industries Ltd.
  • Vectura Group plc.

Ask Analyst for Customization and Browse full report with TOC List of Figure: https://www.imarcgroup.com/request?type=report&id=4892&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Drug Abuse Testing Market Trends & Forecast by 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Drug Abuse Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global drug abuse testing market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the drug abuse testing market?

Report Attributes Details
Market Size in 2022 US$ 6.6 Billion
Market Forecast in 2028 US$ 9.8 Billion
Growth rate (2023 to 2028) CAGR of 6.9%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is drug abuse testing?

Drug abuse refers to the deliberate consumption of illegal substances or the overconsumption of prescribed psychoactive and over-the-counter (OTC) medications. It can affect the mind and body and cause several disorders, including addiction. As a result, drug abuse is diagnosed by using numerous testing methods to treat related problems effectively. Drug abuse testing also aids in managing the mental status of a patient, handling seizure cases in the emergency room, identifying children and newborns at risk of exposure to illicit drugs, etc. It also finds extensive applications in workplaces where job applicants can be tested for drug usage before being hired.

Request for a free sample copy of this report: https://www.imarcgroup.com/drug-abuse-testing-market/requestsample

What are the growth prospects and trends in the drug abuse testing industry?

The growing drug dependency and substance abuse among individuals for their mind-altering characteristics, medical, non-therapeutic and medicinal uses, and other purposes, such as weight loss, enhancing athletic performance, etc., are primarily driving the drug abuse testing market across the globe. In addition to this, the rising awareness about the harmful consequences of drug abuse, which can create prominent safety and health hazards and reduce the productivity and morale of an individual, is further propelling the product demand. Besides this, the escalating need for screening of employees and job applicants for providing a safe workplace and complying with stringent laws and regulations passed by government bodies is acting as another growth-inducing factor. Additionally, the improving technologies utilized by pain management and opioid dependency clinics are fueling the demand for urine drug testing, which is catalyzing the market growth. Moreover, the emergence of automated testing and analysis for drugs of abuse with at-home testing kits is projected to drive the global drug abuse testing market over the forecasted period.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

  • Analyzers
    • Immunoassays Analyzers
    • Chromatographic Devices
    • Breath Analyzers
  • Rapid Testing Devices
    • Urine Testing Devices
    • Oral Fluid Testing Devices
  • Consumables
  • Laboratory Services

Breakup by Sample:

  • Urine
  • Oral Fluid (Saliva)
  • Hair
  • Breath
  • Others

Breakup by End User:

  • Hospitals
  • Diagnostic Laboratories
  • Forensic Laboratories
  • Workplaces
  • Others

Breakup by Region:

  • North America (U.S. & Canada)
  • Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
  • Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
  • Latin America (Brazil, Mexico)
  • Middle East & Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Drägerwerk AG & Co. KGaA
  • Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings
  • Omega Laboratories Inc.
  • Quest Diagnostics Incorporated
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • United States Drug Testing Laboratories Inc.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4388&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

 

Hospital Beds Market Share, Size, Trends | Forecast 2027

According to the latest report by IMARC Group, titled “ Hospital Beds Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 ,” The global hospital beds market  is expected to exhibit a CAGR of 3.9%  during 2022- 2027. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

Industry Definition and Application:

Hospital beds are specialized bedding designed for patients in healthcare facilities to provide comfort and support during their hospital stay. They include electric, semi-electric, and manual beds that adjust to the head and foot positions of the patients and are employed for critical, acute, and long-term care of the patients. They are also used for patient examinations, diagnosis, treatment, and transportation. At present, pediatrics, respiratory, bariatric, birthing, pressure relief, and intensive care unit (ICU) beds are available in hospitals across the globe.

Global Hospital Beds Market Trends:

The growing geriatric population and increasing prevalence of medical conditions are catalyzing the demand for hospitalization. This represents one of the primary factors positively influencing the market around the world. In addition, key market players are introducing powered hospital beds, which facilitate convenient patient transportation, enhanced comfort, position adjustments, mobile monitoring, and fall detection. They are also focusing on manufacturing beds suitable for home settings due to the growing trend of home care, which is bolstering the market growth. Apart from this, inflating disposable incomes and increasing investments in infrastructural development are fueling the market growth. Furthermore, the growing partnerships, agreements,

Request Free Sample Report: https://www.imarcgroup.com/hospital-beds-market/requestsample

Global Hospital Beds Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • GF Health Products Inc.
  • Getinge AB
  • Hill-Rom Holdings Inc.
  • Invacare Corporation
  • Malvestio S.P.A.
  • Stryker Corporation
  • Paramount Bed Holdings Co. Ltd.
  • Savion Industries
  • Span-America Medical Systems Inc. (Savaria Corporation)
  • Stiegelmeyer GmbH & Co. KG.

The report has segmented the market on the basis on region, technology, bed type, usage and end user.

Breakup by Technology:

  • Electric Beds
  • Semi-Electric Beds
  • Manual Beds

Breakup by Bed Type:

  • Regular Beds
  • Pediatrics Bed
  • Respiratory Beds
  • ICU Beds
  • Bariatric Beds
  • Birthing Beds
  • Pressure Relief Beds
  • Others

Breakup by Usage:

  • Critical Care
  • Acute Care
  • Long-Term Care

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2417&flag=C

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin .com/company/imarc-group

Live Cell Imaging Market Size, Share, Industry Trends 2023-2028

According to the latest report by IMARC Group, titled “Live Cell Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028″, The global live cell imaging market size reached US$ 2.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.5 Billion by 2028, exhibiting a growth rate (CAGR) of 9.01% during 2023-2028.

Live cell imaging refers to a microscopy technique that allows in vivo imaging of cell structures. It aids scientists in obtaining valuable information on biological processes, including movement with time resolution and molecular localization. Live cell imaging also assists in studying dynamic complex assembly and interaction between molecules, cellular responses to environmental cues, viral particle behavior, etc. In recent times, numerous technological advancements, such as algorithms and data analysis, are enabling the monitoring of molecules within animals.

Live Cell Imaging Market Trends:

The elevating incidences of chronic and lifestyle diseases and the expanding healthcare provision are driving the live cell imaging market. Furthermore, live cell imaging can be utilized in monitoring exocytosis, endocytosis, protein trafficking, cellular integrity, enzyme activity, signal transduction, etc. As a result, it is gaining preference over fixed cell imaging that usually requires a long exposure time and high illumination intensity. Additionally, various improvements in camera technology, sensitivity, pixel density, etc., are leading to advances in quantitative phase contrast, which is enabling image capture at different focal planes from one exposure. Besides this, several researchers are utilizing live cell imaging to get biologically relevant data as these images can be automatically processed to extract information from dynamic cells. Apart from this, the increasing government funding and investments in medical research and development (R&D) projects are expected to catalyze the market growth over the forecasted period.

Request Free Sample Report: https://www.imarcgroup.com/live-cell-imaging-market/requestsample

Global Live Cell Imaging Market 2023-2028 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Becton Dickinson and Company (BD)
  • Carl Zeiss AG
  • Leica Microsystems (Danaher Corporation)
  • Merck KGaA
  • Nikon Instruments Inc.
  • Olympus Corporation
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.

The report has segmented the market on the basis on region, product, application and technology.

Breakup by Product:

  • Equipment
  • Consumable
  • Software

Breakup by Application:

  • Cell Biology
  • Developmental Biology
  • Stem Cell and Drug Discovery
  • Others

Breakup by Technology:

  • Time-Lapse Microscopy
  • Fluorescence Recovery after Photobleaching (FRAP)
  • Fluorescence Resonance Energy Transfer (FRET)
  • High Content Screening (HCS)
  • Others

Breakup by Region:

  • North America:( United States, Canada)
  • Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico,Others)
  • Middle East and Africa

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023- 2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4101&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

 

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

Autoimmune Disease Diagnosis Market Size, Share, Demand, Key Players, Growth and Industry Trends 2022-27

According to the latest report by IMARC Group, titled “Autoimmune Disease Diagnosis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global autoimmune disease diagnostics market share reached US$ 3.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.1 Billion by 2027, exhibiting a growth rate (CAGR) of 6.4% during 2022-2027.This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

An autoimmune disease refers to a medical condition that results from an abnormal immune response to a normally functioning body part. The immune system is unable to distinguish between healthy tissues and potentially harmful antigens in this condition. As a result, it releases proteins called autoantibodies to attack the healthy cells that destroy the functioning cells, tissues, and organs of the body. At present, more than 80 types of autoimmune disorders have been identified by scientists that include type I diabetes, psoriasis, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. The diagnosis of these diseases requires a combination of physical examination, antinuclear antibody test (ANA), C-reactive protein (CRP), tissue biopsy and X-rays in order to determine the nature and severity of the condition.

Request Free Sample Report: https://www.imarcgroup.com/autoimmune-disease-diagnosis-market/requestsample

Global Autoimmune Disease Diagnosis Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Abbott Laboratories, Aesku.Diagnostics GmbH & Co. KG, Beckman Coulter Inc. (Danaher Corporation), bioMerieux SA (Institut Merieux), Bio-Rad Laboratories Inc., Euroimmun AG (PerkinElmer Inc.), Hemagen Diagnostics Inc., Inova Diagnostics Inc. (Werfen Group S.A.), Myriad Genetics Inc., Quest Diagnostics Incorporated, Siemens Healthineers AG (Siemens AG), SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech, etc.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/autoimmune-disease-diagnosis-market

The report has segmented the market on the basis of product, disease, test, user and Region

Breakup by Product Type:

  • Consumables and Assay Kits

  • Instruments

Breakup by Disease Type:

  • Systemic Autoimmune Disease

  • Localized Autoimmune Disease

Breakup by Test Type:

  • Routine Laboratory Tests

  • Inflammatory Markers

  • Autoantibodies and Immunologic Tests

  • Others

Breakup by End-User:

  • Clinical Laboratories

  • Hospitals

  • Others

Breakup by Region:

North America

Asia Pacific

Europe

Latin America

Middle East and Africa

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800